BOSTON, July 18, 2017 /PRNewswire/ -- GreenLight Biosciences, Inc., a biotechnology company producing novel RNA-based productsfor agricultural, healthcare and other applications, today announced that management will present at the BIO World Congress on Industrial Biotechnology at the Palais des Congres in Montreal, Canada. The presentation
The content of the presentation will be available online from the Media page of the Company's website at www.greenlightbio.com.
GreenLight Biosciences, Inc., is a leader in the development and manufacturing of nucleic acid materials for research, agricultural and healthcare applications. GreenLight's Cell-free Bioprocessing platform enables unprecedented precision, low cost and scalability in the production of RNA-based materials, enabling a broad range of products for pest control and other important agricultural applications. GreenLight is a private company backed by a leading syndicate of notable investors.
Media contact: [email protected]
View original content:http://www.prnewswire.com/news-releases/greenlight-biosciences-to-present-at-the-bio-world-congress-on-industrial-biotechnology-300489572.html
SOURCE GreenLight Biosciences, Inc.
Subscribe to our Free Newsletters!
Yellow fever is a hemorrhagic fever that is transmitted by infected mosquitoes and it can lead to ...
Routes of drug administration play a major role in a medical treatment. Selecting a right route of ...
Spinal anesthesia and epidural anesthesia are types of regional anesthesia in which when a drug is ...View All